Related Experiment Video
Updated: Apr 20, 2026

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
Growing up with spinal muscular atrophy with respiratory distress (SMARD1)
Mark James Hamilton1, Cheryl Longman1, Ann O'Hara2
1West of Scotland Clinical Genetics Service, Southern General Hospital, Glasgow, United Kingdom.
Insights
Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is a genetic neuromuscular disorder. This case study highlights adult SMARD1 patients may experience stable symptoms and lead integrated lives.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Background:
- Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is an inherited neuromuscular disorder caused by IGHMBP2 gene mutations.
- SMARD1 typically presents in infancy with progressive weakness and respiratory distress due to diaphragmatic dysfunction.
- Limited data exists on the long-term phenotype of SMARD1 in adulthood.
Observation:
- Clinical heterogeneity is noted in childhood SMARD1, but adult phenotypes are less documented.
- This report details a 21-year-old female with genetically confirmed SMARD1.
Findings:
- The patient exhibits stable muscle weakness and normal cognition.
- She maintains a socially integrated lifestyle, requiring only overnight mechanical ventilation.
Implications:
- This case expands the understanding of SMARD1 clinical variability into adulthood.
- It suggests a potentially more favorable long-term prognosis for some individuals with SMARD1.
Abstract:
Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is an inherited neuromuscular condition resulting from recessive mutations in the immunoglobulin mu-binding protein (IGHMBP2) gene. Affected individuals characteristically present in infancy with progressive distal weakness and respiratory distress secondary to diaphragmatic weakness. Considerable clinical heterogeneity has been described both in its presentation and phenotype in childhood; however little data pertaining to phenotype in adulthood have been reported to date. This report describes a 21 year old woman with genetically confirmed SMARD1 who has stable muscle weakness, normal cognitive abilities and is able to lead a socially integrated lifestyle, using mechanical ventilation only overnight. This report adds new evidence for clinical variability throughout the course of SMARD1.
More Related Videos
09:24Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease
Published on: April 17, 2017
06:52Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
Published on: September 29, 2014
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Skeletal Muscle Relaxants: Therapeutic Uses
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Breathing
Myasthenia Gravis ll: Pathophysiology